Cargando…
MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum
Autores principales: | Yang, Renjie, Wang, Dong, Han, Shen, Gu, Yichao, Li, Zhi, Deng, Lei, Yin, Aihong, Gao, Yun, Li, Xiangcheng, Yu, Yue, Wang, Xuehao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295052/ https://www.ncbi.nlm.nih.gov/pubmed/35864960 http://dx.doi.org/10.7150/ijbs.75760 |
Ejemplares similares
-
MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs
por: Yang, Renjie, et al.
Publicado: (2022) -
Sarcomatous intrahepatic cholangiocarcinoma: Case report and literature review: Erratum
Publicado: (2018) -
Erratum to: Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma
por: Tsujie, Masanori, et al.
Publicado: (2021) -
Influence of marital status on the survival of adults with extrahepatic/intrahepatic cholangiocarcinoma
por: Chen, Zhiqiang, et al.
Publicado: (2017) -
Angiotensin receptor blockers retard the progression and fibrosis via inhibiting the viability of (AGTR1+)CAFs in intrahepatic cholangiocarcinoma
por: Li, Jian‐Hui, et al.
Publicado: (2023)